Evidence map›Paper›PMID 42707838›Full record

ArticleWorld journal of critical care medicine2026

Characterizing the molecular landscape of venous congestion.

Logan R Van Nynatten, Karina Nabieva, Gemma Barber, Jonathan J Moroniti, Alla Iansavitchene, Ross Prager, Marat Slessarev, John Basmaji, Aleksandra Leligdowicz

Abstract read
In one paragraph

Article in World journal of critical care medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Logan R Van NynattenDepartment of Critical Care Medicine, Western University, Ontario N6A5A5, Canada.
Karina NabievaDepartment of Critical Care Medicine, Western University, Ontario N6A5A5, Canada.
Gemma BarberDepartment of Critical Care Medicine, Western University, Ontario N6A5A5, Canada.
Jonathan J MoronitiDepartment of Critical Care Medicine, Western University, Ontario N6A5A5, Canada.
Alla IansavitcheneDepartment of Critical Care Medicine, Western University, Ontario N6A5A5, Canada.
Ross PragerDepartment of Critical Care Medicine, Western University, Ontario N6A5A5, Canada.
Marat SlessarevDepartment of Critical Care Medicine, Western University, Ontario N6A5A5, Canada.
John BasmajiDepartment of Critical Care Medicine, Western University, Ontario N6A5A5, Canada.
Aleksandra LeligdowiczDepartment of Critical Care Medicine, Western University, Ontario N6A5A5, Canada. aleks.leligdowicz@lhsc.on.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVenous congestion is a pathologic state caused by reduced arteriovenous gradients that promote injurious tissue edema. Venous congestion can be due to etiologies such as decompensated cardiac disease, renal failure, or iatrogenic fluid administration. However, the underlying pathobiology of venous congestion is poorly investigated, particularly in critical illness. We conducted a scoping review to identify candidate circulating proteins potentially associated with venous congestion pathobiology.

aimTo identify circulating proteins associated with the pathobiology of venous congestion.

methodsThe MEDLINE and EMBASE databases were searched for articles relevant to venous congestion. Studies were included if they: (1) Investigated human adult subjects ≥ 18 years of age; (2) Measured plasma or serum proteins in disease states with reported measures of venous congestion; and (3) Reported clinical or ultrasound measures of assessing venous congestion. Preferred Reporting Items for Systematic Reviews and Meta-analysis extension for scoping reviews guidelines were used.

resultsA total of 3860 abstracts were eligible for screening, of which 171 manuscripts underwent full-text review, and 145 texts met inclusion criteria. The median number of circulating proteins measured was 2 (interquartile range: 1-3). Most studies (116, 80%) reported measures of venous congestion in the context of cardiac disease. Five studies (3%) were performed in a critical care setting. Significant variability was noted in the reported measures of venous congestion, with physical examination often used to presume the presence of venous congestion (45% of studies). Less than 30% of studies had the objective of investigating circulating proteins, and less than 15% of studies aimed to characterize biology of venous congestion. The candidate circulating plasma proteins measured included proteins related to myocardial function, endothelial function, and inflammation.

conclusionWe present the first scoping review identifying circulating proteins with a possible role in mediating venous congestion at a molecular level. To date, no robust studies have comprehensively investigated the biology of venous congestion. These data provide a foundation for further studies of the biological mechanisms of venous congestion. Understanding these mechanisms may assist in the measurement of responses to volume resuscitation, stratification in clinical trials focusing on appropriate volume administration and removal, and the identification of novel therapies that target pathways implicated in this deleterious condition.

Indexed as

BiomarkersCritical careProteomicsUltrasoundVenous congestion

Identifiers

PMID42707838
PMCPMC13548146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.